News

Fierce Biotech1d
Minovia brings back SPAC with plans to skate into icy public market
While the IPO landscape remains icy, Minovia Therapeutics is skating into the market using a special purpose acquisition ...
Agence France-Presse5d
Positive Late-Breaking Data for Incyte’s First-in-Class mutCALR-targeted therapy INCA033989 in Essential Thrombocythemia Presented at EHA2025
Israel launches strikes on missile facilities in central Iran: air force Incyte (Nasdaq:INCY) today announced the first clinical data from two studies evaluating the safety, tolerability and efficacy ...
ahajournals.org3d
Mitochondrial 1-Carbon Metabolism Drives CD34-Lineage Cells to Differentiate Into T Follicular Helper Cells to Form Tertiary Lymphoid Organs in Transplant Arteriosclerosis ...
CD34-lineage cells differentiate into T cells and enhance tertiary lymphoid organ formation in allograft artery. A, Experimental scheme depicting the tamoxifen-induced CD34-lineage cell labeling, ...
Sickle Cell Disease News2d
BEAM-101 shows sustained benefits as treatment for sickle cell
BEAM-101, a treatment for sickle cell disease, showed sustained efficacy and safety over one year in the BEACON Phase 1/2 ...
Taiwan News1d
Vietnam Cell and Tissue Preservation Market Set for Growth from 2024 to 2032 Amid Advancements in Biobanking and Regenerative Medicine
Request To Download Free Sample of This Strategic Report @ This country research report on Vietnam Cell and Tissue Preservation Market offers comprehensive insights into the market landscape, ...